Overview

Early Treatment for Acute ACL Tear

Status:
Completed
Trial end date:
2017-02-05
Target enrollment:
Participant gender:
Summary
This research study is the first of its kind and will allow health care professionals and researchers to answer many questions about the reasons why anterior cruciate ligament (ACL) injury leads to knee pain and disability and osteoarthritis. We also hope that this study will be the beginning of new, more powerful and safer drugs to help patients with ACL injuries heal sooner and return to sports or daily activities pain free. Study participants will be recruited from the University of Kentucky and Vanderbilt University. The purpose of this research is to gather information on how safe and effective KenalogĀ® is in alleviating knee pain following ACL rupture.
Phase:
Phase 2
Details
Lead Sponsor:
Cale Jacobs
Christian Lattermann
Collaborator:
Vanderbilt University
Treatments:
Pharmaceutical Solutions
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide